Anne K Ellis Selected Research

3- fluoro- 3- (3- fluoro- 4- (pyrrolidin- 1- ylmethyl)phenyl)- N- (2- methylpropyl)cyclobutanecarboxamide

1/2014

Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne K Ellis Research Topics

Disease

39	Allergic Rhinitis 12/2021 - 10/2003
21	Hypersensitivity (Allergy) 01/2022 - 08/2005
11	Asthma (Bronchial Asthma) 06/2022 - 02/2006
11	Anaphylaxis (Anaphylactic Shock) 12/2021 - 01/2003
8	Seasonal Allergic Rhinitis (Hay Fever) 07/2021 - 07/2005
4	Infections 01/2022 - 07/2020
3	COVID-19 01/2022 - 01/2021
3	Conjunctivitis 12/2021 - 01/2018
3	Inflammation (Inflammations) 01/2021 - 06/2014
3	Rhinitis 01/2021 - 05/2006
2	Eosinophilia 10/2011 - 05/2006
2	Obstructive Sleep Apnea 01/2007 - 05/2006
2	Sleepiness 07/2005 - 10/2003
1	Eosinophilic Esophagitis 12/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2021
1	red meat allergy 11/2021
1	Food Hypersensitivity (Food Allergy) 11/2021
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Human Influenza (Influenza) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Symptom Flare Up 01/2020
1	Rhinosinusitis 01/2018
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2018
1	AIDS-Related Complex (ARC) 08/2017
1	Cough 01/2017
1	Proteinuria 01/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Perinatal Death 01/2015
1	Atopic Dermatitis (Atopic Eczema) 07/2013
1	Drug Hypersensitivity Syndrome 10/2011
1	Pneumonia (Pneumonitis) 10/2011

Drug/Important Bio-Agent (IBA)

34	AllergensIBA 12/2021 - 05/2006
8	TabletsIBA 12/2021 - 01/2018
7	ragweed pollenIBA 12/2021 - 10/2003
7	Histamine Antagonists (Antihistamines)IBA 11/2021 - 02/2006
6	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 02/2006
6	Epinephrine (Adrenaline)FDA LinkGeneric 12/2021 - 01/2003
4	Loratadine (Alavert)FDA Link 01/2021 - 05/2009
3	Immunoglobulin E (IgE)IBA 11/2021 - 12/2009
3	fexofenadine (Allegra)FDA LinkGeneric 04/2021 - 07/2005
3	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2017
3	SteroidsIBA 04/2015 - 10/2011
2	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 06/2022 - 03/2020
2	EpitopesIBA 11/2021 - 08/2017
2	COVID-19 VaccinesIBA 10/2021 - 03/2021
2	VaccinesIBA 03/2021 - 01/2021
2	Nasal SpraysIBA 01/2021 - 01/2013
2	Peptides (Polypeptides)IBA 01/2021 - 08/2017
2	VenomsIBA 01/2015 - 08/2005
2	Cetirizine (Zyrtec)FDA LinkGeneric 01/2013 - 07/2005
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2007 - 05/2006
1	Formoterol Fumarate (Oxis)FDA Link 06/2022
1	Budesonide (Pulmicort)FDA LinkGeneric 06/2022
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2022
1	Succinic Acid (Succinate)IBA 01/2022
1	methionine sulfoxideIBA 01/2022
1	CarnosineIBA 01/2022
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2022
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2022
1	rupatadineIBA 12/2021
1	CarbohydratesIBA 11/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2021
1	Polysorbates (PSML)FDA Link 10/2021
1	Excipients (Suspending Agents)IBA 10/2021
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 04/2021
1	Vehicle Emissions (Emissions, Vehicle)IBA 04/2021
1	Air Pollutants (Pollutants, Air)IBA 04/2021
1	Arthropod VenomsIBA 03/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2021
1	InterferonsIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Bispecific AntibodiesIBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2021
1	Pseudoephedrine FDA LinkGeneric 01/2021
1	beta-LactamsIBA 11/2020
1	LactamsIBA 11/2020
1	GlucocorticoidsIBA 01/2020
1	Dac g 5 allergenIBA 08/2017
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 08/2017
1	SmokeIBA 01/2017
1	Biological ProductsIBA 01/2017
1	Nasal Decongestants (Decongestants)IBA 04/2015
1	phthalic acid (phthalate)IBA 06/2014
1	Pharmaceutical PreparationsIBA 06/2014
1	3- fluoro- 3- (3- fluoro- 4- (pyrrolidin- 1- ylmethyl)phenyl)- N- (2- methylpropyl)cyclobutanecarboxamideIBA 01/2014
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2014
1	Calcineurin InhibitorsIBA 07/2013
1	azelastine (Optivar)FDA LinkGeneric 01/2013

Therapy/Procedure

15	Immunotherapy 12/2021 - 08/2005
9	Therapeutics 01/2021 - 11/2002
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
1	Ambulatory Care (Outpatient Care) 07/2020
1	Injections 01/2018
1	Emergency Treatment 09/2017
1	Biological Therapy 01/2017
1	Secondary Prevention 05/2016